drugset
drugset / Trial / NCT04612517

A Multiple Ascending Dose Trial Assessing Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZP7570

NCT04612517 ↗

Phase 0 Completed 40 enrolled Zealand Pharma
RandomizedParallel-groupTriple-blindTreatment

Summary

This is a randomised, double-blind, placebo-controlled, multiple ascending dose trial in healthy subjects, randomised to ZP7570 or placebo within each cohort

Timeline

Start
2020-10-26
Primary completion
2021-08-30
Completion
2021-08-30

Drugs

EvaluationDrugModalityDoseRoute
Subject ZP7570 Unknown — Subcutaneous

Indications

No indication recorded.